STAA
NASDAQ HealthcareSTAAR Surgical Company - Common Stock
Medical Instruments & Supplies
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
�� 市场数据
| 价格 | $25.08 |
|---|---|
| 成交量 | 879,926 |
| 市值 | 1.24B |
| 贝塔系数 | 1.040 |
| RSI（14日） | 78.4 超买 |
| 200日均线 | $23.01 |
| 50日均线 | $19.42 |
| 52周最高 | $30.81 |
| 52周最低 | $15.59 |
| Forward P/E | 32.57 |
| Price / Book | 3.60 |
🎯 投资策略评分
STAA 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (67/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 💰 Dividend Daddy (25/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 STAA in your text
粘贴任何文章、记录或帖子 — 工具将提取 STAA 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.